| (Values in U.S. Thousands) | Mar, 2025 | Mar, 2024 | Mar, 2022 | Mar, 2021 | Mar, 2020 |
| Sales | 246,720 | 200,360 | 174,880 | 191,440 | 207,950 |
| Sales Growth | +23.14% | +14.57% | -8.65% | -7.94% | +11.04% |
| Net Income | 1,630 | -48,620 | -1,357,100 | -542,590 | -2,468,190 |
| Net Income Growth | +103.35% | +96.42% | -150.12% | +78.02% | -1,023.59% |
Aurora Cannabis Inc (ACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents.
Fiscal Year End Date: 03/31